Rotigotine

Neupro

Nonergot Dopamine Agonist

NADAC/unit $28.2081

No Shortage Tier 1: 29.2% PA Req: 5.5%

NEUPRO is a dopamine agonist indicated for the treatment of: Parkinson's disease ( 1.1 ) Moderate-to-severe primary Restless Legs Syndrome ( 1.2 ) 1.1 Parkinson's Disease (PD) NEUPRO is indicated f....

vs. brand Neupro: Generic saves up to -182% per unit

Covered Lives

Generic Manufacturers

UCB INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Rotigotine drfinder.aiFind doctors who prescribe Rotigotine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Rotigotine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.